189 related articles for article (PubMed ID: 26611598)
1. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Suzuki M; Svendsen CN
Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.
Krakora D; Mulcrone P; Meyer M; Lewis C; Bernau K; Gowing G; Zimprich C; Aebischer P; Svendsen CN; Suzuki M
Mol Ther; 2013 Aug; 21(8):1602-10. PubMed ID: 23712039
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
4. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
6. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
[TBL] [Abstract][Full Text] [Related]
7. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis.
Mohajeri MH; Figlewicz DA; Bohn MC
Hum Gene Ther; 1999 Jul; 10(11):1853-66. PubMed ID: 10446925
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
10. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1
Řehořová M; Vargová I; Forostyak S; Vacková I; Turnovcová K; Kupcová Skalníková H; Vodička P; Kubinová Š; Syková E; Jendelová P
Stem Cells Transl Med; 2019 Jun; 8(6):535-547. PubMed ID: 30802001
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.
Kliem MA; Heeke BL; Franz CK; Radovitskiy I; Raore B; Barrow E; Snyder BR; Federici T; Kaye Spratt S; Boulis NM
Amyotroph Lateral Scler; 2011 Sep; 12(5):331-9. PubMed ID: 21864053
[TBL] [Abstract][Full Text] [Related]
13. GDNF delivery using human neural progenitor cells in a rat model of ALS.
Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
[TBL] [Abstract][Full Text] [Related]
14. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as trojan horses for GDNF delivery in ALS.
Kaspar BK
Mol Ther; 2008 Dec; 16(12):1905-6. PubMed ID: 19023270
[No Abstract] [Full Text] [Related]
18. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
19. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
20. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
